Schonfeld Strategic Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-640
| Closed | -$12.8K | – | 2711 |
|
|
2022
Q4 | $12.8K | Sell |
640
-375
| -37% | -$7.5K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $18K | Hold |
1,015
| – | – | ﹤0.01% | 2647 |
|
|
2022
Q2 | $23K | Sell |
1,015
-10
| -1% | -$227 | ﹤0.01% | 2208 |
|
|
2022
Q1 | $28K | Buy |
+1,025
| New | +$28K | ﹤0.01% | 2308 |
|
|
2021
Q3 | – | Sell |
-813
| Closed | -$77K | – | 2421 |
|
|
2021
Q2 | $77K | Sell |
813
-4,247
| -84% | -$402K | ﹤0.01% | 1808 |
|
|
2021
Q1 | $842K | Buy |
5,060
+1,520
| +43% | +$253K | 0.01% | 922 |
|
|
2020
Q4 | $347K | Buy |
+3,540
| New | +$347K | ﹤0.01% | 1120 |
|